Discontinued — last reported Q1 '26
Merck & Co. Other — Sales decreased by 13.4% to $679.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 3.1%, from $701.00M to $679.00M. Over 4 years (FY 2021 to FY 2025), Other — Sales shows an upward trend with a 23.9% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates successful market penetration or growth in secondary geographic regions, while a decrease may signal market saturation or divestment in those areas.
This metric represents the total revenue generated from geographic regions or business activities categorized as 'Other'...
Peers typically report similar 'Rest of World' or 'Other' geographic revenue segments, which are often used to track international expansion efforts.
mrk_segment_other_sales| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $207.00M | $379.00M | $397.00M | $534.00M | $637.00M | $698.00M | $699.00M | $545.00M | $491.00M | $469.00M | $599.00M | $621.00M | $612.00M | $624.00M | $702.00M | $701.00M | $595.00M | $798.00M | $784.00M | $679.00M |
| QoQ Change | — | +83.1% | +4.7% | +34.5% | +19.3% | +9.6% | +0.1% | -22.0% | -9.9% | -4.5% | +27.7% | +3.7% | -1.4% | +2.0% | +12.5% | -0.1% | -15.1% | +34.1% | -1.8% | -13.4% |
| YoY Change | — | — | — | — | +207.7% | +84.2% | +76.1% | +2.1% | -22.9% | -32.8% | -14.3% | +13.9% | +24.6% | +33.0% | +17.2% | +12.9% | -2.8% | +27.9% | +11.7% | -3.1% |